REQUEST A DEMO
Total
USD $0.00
Search more companies

Dogmar Pharmaceutical S.A. (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Dogmar Pharmaceutical S.A. Profile Updated: August 02, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Dogmar Pharmaceutical S.A. is based in Ecuador. The head office is in Eloy Alfaro. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. The company was established on July 13, 2020. 4 (2023) employees currently work for Dogmar Pharmaceutical S.A.. The company’s latest financial report indicates a net sales revenue drop of 26.35% in 2023. A negative growth of 98.04% was recorded in its total assets. The net profit margin of Dogmar Pharmaceutical S.A. decreased by 8.38% in 2023.

Headquarters
Via Duran Boliche, Km 3
Eloy Alfaro; Guayas;

Contact Details: Purchase the Dogmar Pharmaceutical S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Dogmar Pharmaceutical S.A. report to view the information.
Outstanding Shares:
Purchase the Dogmar Pharmaceutical S.A. report to view the information.
Registered Capital:
Purchase the Dogmar Pharmaceutical S.A. report to view the information.
Incorporation Date:
July 13, 2020
Key Executives
Purchase this report to view the information.
General Manager
Company Performance
Financial values in the chart are available after Dogmar Pharmaceutical S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-26.35%
Total operating revenue
-26.35%
Operating profit (EBIT)
N/A
Net Profit (Loss) for the Period
-98.37%
Total assets
-98.04%
Total equity
-95.36%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
-8.38%
Return on Equity (ROE)
-45%
Quick Ratio
11.73%
Cash Ratio
5.84%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?